Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | 3,000,000 | reported | 03 Feb 2026 | tx 18+14,846,781 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Feb 2026 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 3,000,000 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 3,000,000 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 46,528 | 0.00 USD | deriv |
| 15 Jul 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 4,447 | 0.00 USD | deriv |
| 21 Feb 2024 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 190,000 | 0.00 USD | deriv |
| 07 Dec 2023 | PURCHASE | SAB Biotherapeutics, Inc. | 1,740 | 0.88 USD | first after silence |
| 14 Mar 2023 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 525,000 | 0.00 USD | deriv |
| 13 Sept 2022 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 07 Sept 2022 | PURCHASE | SAB Biotherapeutics, Inc. | 14,000 | 0.74 USD | |
| 16 Mar 2022 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 21,218 | 0.00 USD | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 5,213,764 | — | |
| 07 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 2,800 | 10.07 USD | |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 23,264 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 162,850 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 162,850 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 139,585 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 197,374 | — | deriv |
| 22 Oct 2021 | GRANT_AWARD | SAB Biotherapeutics, Inc. | 2,106,361 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 07 Dec 2023.